NCT02842242 - A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions

Cardiomyopathy, Hypertrophic ObstructiveLeft Ventricular Outflow Tract Obstruction

Interventions

DRUG

MYK-461

Trial Locations (7)

Mayo Clinic Arizona, Scottsdale

Yale New Haven Hospital, New Haven

Tufts Medical Center, Boston

Washington University St. Louis, St Louis

Duke Health Center at Southpoint, Durham

Oregon Health and Science University, Portland

Hospital of the University of Pennsylvania (Penn Heart and Vascular Center), Philadelphia